• Introduction
  • Experience
  • Project Management
  • Quality
  • Locations
• IVRS / IWRS - IXRS
  • IXR Express
  • Dynamic Patient Randomisation and Dosing
  • Patient Tracking & Management
  • Clinical Trials Materials Management
  • Clinical Supply Management
• Reporting
  • Features
  • Suites of Reports
• ePRO
  • Why Use ePRO?
• Statistical Services
  • Dynamic Patient Randomisation & Dosing
  • Adaptive Trial Design
  • Psychometric Services for ePRO
• Web Drug Reconciliation
• Data Integration & Reporting
  • Reporting
  • Ad-hoc Reporting
• Clinical Hotline
• Technical Support

Almac Clinical Technologies Experiences

Since 1995, Almac Clinical Technologies’ systems have been used in over 1300 clinical trials involving more than 100,000 sites, and over 1,500,000 patients in more than 80 countries using 50+ different languages.

Our experience spans all phases of clinical trial development and numerous therapeutic areas. We have particular expertise in oncology, inflammation, endocrine/metabolic, infectious diseases, and CNS, and have conducted an average of 150 studies in each of those categories.

Given our clients’ diverse requirements, Almac has developed its technologies to efficiently manage trials of all sizes. As a global market leader, Almac is often relied upon by clients for large, complex, multinational, multi-site trials. Yet, we are also required to manage smaller and simpler studies both regionally and globally.  As a result, we have amassed over 550 Phase I-II studies and more than 775 Phase III-IV trials.

Almac Clinical Technologies’ 200+ clients range from 18 of the 20 largest biopharmaceutical companies, to many of the top 50 pharma, and several medium and small-sized biopharmaceutical companies.